V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 330008297 | 330005082 | 1.63 | 69 | Palliative (P) | 2015-08-06 | 2015-10-16 | Cisplatin + Doxorubicin | 02 | N | 330016591 | NIVOLUMAB |
| 330008298 | 330005083 | 1.8 | 64.1 | Curative (C) | 2014-06-30 | 2014-07-21 | Cytarabine High Dose | 02 | N | 330016621 | CYTARABINE HIGH DOSE |
| 330008299 | 330005083 | 1.79 | 72.4 | Palliative (P) | 2015-02-19 | 2015-06-11 | EURO-EWING | 02 | N | 330016621 | EURO-EWING |
| 330008300 | 330005084 | 1.63 | 94.7 | Palliative (P) | 2013-06-08 | 2013-07-21 | TEMOZOLOMIDE | 02 | N | 330016630 | DA |
| 330008301 | 330005084 | 1.7 | 51.2 | Palliative (P) | 2017-05-28 | 2017-05-28 | Irinotecan + Temozolomide | 02 | N | 330016630 | IRINOTECAN + TEMOZOLOMIDE |
| 330008302 | 330008781 | 0 | 58.1 | Disease modification (D) | 2016-05-31 | 2016-06-01 | Liposomal Doxorubicin (Caelyx) | 2 | N | 330016671 | LIPOSOMAL DOXORUBICIN |
| 330008303 | 330008781 | 1.55 | 55.8 | Palliative (P) | 2016-05-24 | 2016-06-05 | CISPLATIN + ETOPOSIDE | N | N | 330016671 | CYCLOPHOSPHAMIDE + TOPOTECAN |
| 330008304 | 330008781 | 1.7 | 69 | Palliative (P) | 2013-11-01 | 2013-12-20 | Trabectedin | N | N | 330016671 | TRABECTEDIN |
| 330008305 | 330008781 | 1.71 | 81.05 | Disease modification (D) | 2016-05-15 | 2016-06-25 | EW EuroEwing 2012 Arm A VIDE | null | N | 330016671 | EURO-EWING |
| 330008306 | 330005087 | 1.75 | 63 | Curative (C) | 2016-12-27 | 2017-02-10 | AML Int Guide HD Cytarabine (3 + 4) | N | N | 330016697 | CYTARABINE HIGH DOSE |
| 330008308 | 330005090 | 1.6 | 28.1 | Neo-adjuvant (N) | 2016-08-27 | 2016-12-10 | Cisplatin + Doxorubicin | null | N | 330016723 | CAV |
| 330008311 | 330005094 | 1.67 | 15.8 | Palliative (P) | 2016-09-07 | 2016-09-08 | Cyclophosphamide + Topotecan | N | N | 330016730 | CAV |
| 330008314 | 330008785 | null | 59 | Palliative (P) | 2017-06-28 | 2017-08-08 | DA 3+8 | 02 | N | 330016751 | VINBLASTINE |
| 330008315 | 330008785 | 0 | 68 | Palliative (P) | 2013-05-12 | 2013-05-17 | Cisplatin + Etoposide po&iv 3 day | N | N | 330016751 | CAV |
| 330008316 | 330005098 | 0 | 92.2 | Palliative (P) | 2017-03-27 | 2017-03-28 | Cisplatin + Etoposide (3 day) | 02 | null | 330016778 | CYCLOPHOSPHAMIDE + TOPOTECAN |
| 330008317 | 330008786 | null | 66.4 | Curative (C) | 2015-02-03 | 2015-02-05 | Etoposide oral | N | N | 330016781 | ETOPOSIDE |
| 330008318 | 330008786 | 1.84 | 113 | Not known (9) | 2018-02-15 | 2018-02-26 | Liposomal Doxorubicin (Caelyx) | N | N | 330016781 | LIPOSOMAL DOXORUBICIN |
| 330008319 | 330008786 | 1.61 | 62.4 | Curative (C) | 2014-04-20 | 2014-05-02 | Cisplatin + Etoposide po&iv 3 day | N | N | 330016781 | NIVOLUMAB |
| 330008320 | 330008786 | 1.6 | 70.5 | Curative (C) | 2016-11-14 | 2016-11-19 | Azacitidine | 2 | N | 330016781 | TEMOZOLOMIDE |
| 330008321 | 330008786 | 1.6 | 68.2 | Palliative (P) | 2014-04-26 | 2014-05-08 | Cisplatin + Etoposide (3 day) | N | N | 330016781 | CYCLOPHOSPHAMIDE + TOPOTECAN |
| 330008322 | 330005099 | 1.58 | 37 | Neo-adjuvant (N) | 2014-01-14 | 2014-01-16 | Cisplatin + Doxorubicin | 02 | null | 330016821 | DA |
| 330008323 | 330005102 | 1.8 | 67 | Palliative (P) | 2017-07-24 | 2017-07-24 | Cisplatin + Etoposide (5 day) | N | N | 330016822 | AZACITIDINE |
| 330008324 | 330005103 | 0 | null | Curative (C) | 2013-12-21 | 2013-12-31 | FLAG + Idarubicin | 02 | N | 330016828 | FLAG + IDARUBICIN |
| 330008325 | 330005105 | 1.69 | 29 | Palliative (P) | 2016-06-04 | 2016-06-09 | Cisplatin + Doxorubicin | N | N | 330016830 | TEMOZOLOMIDE |
| 330008326 | 330005106 | 1.79 | 74.1 | Palliative (P) | 2014-05-21 | 2014-05-27 | Trabectedin | 02 | null | 330016890 | TRABECTEDIN |
| 330008327 | 330008790 | 1.7 | 51.4 | Palliative (P) | null | 2014-06-10 | Azacitidine | N | N | 330016918 | CAV |
| 330008328 | 330005109 | 1.66 | 62.2 | Palliative (P) | 2017-08-12 | 2017-08-19 | Etoposide oral | 02 | N | 330016923 | ETOPOSIDE |
| 330008329 | 330005111 | 1.79 | 109.2 | Curative (C) | null | 2016-02-08 | Trabectedin | null | null | 330016923 | TRABECTEDIN |
| 330008330 | 330005112 | 0 | 75 | Palliative (P) | 2014-09-30 | 2014-10-21 | Cytarabine High Dose | 02 | N | 330016929 | CYTARABINE HIGH DOSE |
| 330008331 | 330005112 | 1.67 | 69.6 | Curative (C) | 2013-08-30 | 2013-08-30 | Trabectedin | 2 | N | 330016929 | TRABECTEDIN |
| 330008332 | 330005112 | 0 | 62.1 | Curative (C) | 2013-11-04 | 2013-11-04 | Liposomal Doxorubicin (Caelyx) | N | N | 330016929 | LIPOSOMAL DOXORUBICIN |
| 330008333 | 330005116 | 1.78 | 82.9 | Curative (C) | 2016-10-18 | 2016-10-18 | FLAG + Idarubicin | N | N | 330016967 | FLAG + IDARUBICIN |
| 330008334 | 330005118 | 1.61 | 48.3 | Neo-adjuvant (N) | 2012-09-29 | 2013-02-06 | EW EuroEwing 99 : VActI | N | N | 330016972 | EURO-EWING |
| 330008335 | 330010766 | 0 | 114 | Palliative (P) | 2016-07-22 | 2016-07-22 | Cyclophosphamide + Topotecan | 01 | N | 330016976 | NIVOLUMAB |
| 330008336 | 330010766 | 1.33 | 49.4 | Neo-adjuvant (N) | 2016-05-02 | 2016-05-02 | VAC | null | null | 330016976 | DA |
| 330008337 | 330013183 | 1.58 | 64.7 | null | 2016-03-06 | 2016-03-09 | Cyclophosphamide + Topotecan | N | N | 330017013 | NIVOLUMAB |
| 330008338 | 330005126 | 1.59 | 12 | Curative (C) | 2013-04-24 | 2013-06-09 | Vinblastine | 02 | N | 330017013 | CYCLOPHOSPHAMIDE + TOPOTECAN |
| 330008339 | 330005126 | 1.59 | 56.9 | Curative (C) | 2014-12-10 | 2016-05-04 | Cytarabine High Dose | N | N | 330017013 | CYTARABINE HIGH DOSE |
| 330008340 | 330005128 | 1.67 | 103.4 | Palliative (P) | 2014-02-22 | 2014-02-22 | AML Int Guide HD Cytarabine (3 + 4) | N | null | 330017048 | CYTARABINE HIGH DOSE |
| 330008341 | 330005129 | 1.6 | 42 | Neo-adjuvant (N) | 2014-01-30 | 2014-07-03 | NIVOLUMAB | N | N | 330017052 | CYCLOPHOSPHAMIDE + TOPOTECAN |
| 330008342 | 330010768 | 1.7 | 76.5 | Palliative (P) | 2016-01-04 | 2016-03-30 | CNS Low Grade Glioma Vinblastine | N | N | 330017052 | VINBLASTINE |
| 330008343 | 330012844 | 1.74 | 85.7 | Palliative (P) | 2017-10-01 | 2017-10-17 | Cytarabine High Dose | N | null | 330017083 | CYTARABINE HIGH DOSE |
| 330008344 | 330012844 | 1.66 | null | Disease modification (D) | 2016-12-26 | 2016-12-26 | Methotrexate intrathecal | N | N | 330017083 | METHOTREXATE INTRATHECAL |
| 330008345 | 330012844 | 1.6 | null | Adjuvant (A) | 2013-11-24 | 2013-11-27 | Azacitidine | 2 | N | 330017083 | CISPLATIN + DOXORUBICIN |
| 330008346 | 330005132 | 1.8 | 79.5 | Curative (C) | 2014-02-03 | 2014-02-14 | TEMOZOLOMIDE | N | N | 330017087 | DA |
| 330008347 | 330005133 | null | 102.3 | Curative (C) | 2015-04-17 | 2015-05-05 | Methotrexate intrathecal | N | null | 330017091 | METHOTREXATE INTRATHECAL |
| 330008348 | 330010769 | 1.62 | 61.2 | Palliative (P) | 2013-10-11 | 2013-10-25 | GemCarbo Days 1+8 | N | null | 330017091 | GEMCARBO |
| 330008349 | 330010769 | 1.84 | 69.9 | Curative (C) | 2017-01-18 | 2017-01-23 | Cytarabine High Dose | N | N | 330017091 | CYTARABINE HIGH DOSE |
| 330008350 | 330008806 | null | 67.5 | Curative (C) | 2013-10-09 | 2013-10-16 | DA 3+8 | N | N | 330017120 | VINBLASTINE |
| 330008351 | 330005135 | 1.76 | 66.4 | Disease modification (D) | 2013-03-08 | 2013-05-23 | EW EuroEwing 99 : VIDE | N | N | 330017130 | EURO-EWING |